Seres Therapeutics Inc (MCRB) is destined for greater heights as its last quarter sales were 0 K
Seres Therapeutics Inc (NASDAQ: MCRB) on Monday, soared 2.96% from the previous trading day, before settling in for the closing price of $0.92. Within the